Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis
Abstract Background Coagulopathy has been reported in severely ill patients with coronavirus disease 2019 (COVID‐19). It is unclear whether outpatients with COVID‐19 who are treated with vitamin K antagonists (VKAs) have unstable anticoagulation. Objective To assess the stability of VKA therapy in p...
Guardado en:
Autores principales: | Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter, The Dutch COVID & Thrombosis Coalition |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c754c07dfc24c7da8229b72505e669e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
por: Gilda Denise Zielinski, et al.
Publicado: (2020) -
Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
por: Joseph R. Shaw, et al.
Publicado: (2020) -
Direct oral anticoagulants; a review for the non-specialist
por: Thilina Gunawardena
Publicado: (2021) -
Trombolisis endovenosa post reversión de acenocumarol con complejo de protrombina. Caso clínico
por: Navia,Víctor, et al.
Publicado: (2019) -
Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report
por: Jie Ge, et al.
Publicado: (2021)